USD 0.06
(-0.16%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 755.98 Thousand USD | 9.94% |
2022 | 687.64 Thousand USD | 213.99% |
2021 | 219 Thousand USD | -60.89% |
2020 | 559.95 Thousand USD | 53.08% |
2019 | 365.78 Thousand USD | 4404.19% |
2018 | 8121.00 USD | -98.2% |
2017 | 450.82 Thousand USD | 37.31% |
2016 | 328.32 Thousand USD | 13.39% |
2015 | 289.56 Thousand USD | -46.65% |
2014 | 542.77 Thousand USD | -13.19% |
2013 | 625.22 Thousand USD | 9.3% |
2012 | 572 Thousand USD | 412.05% |
2011 | 111.7 Thousand USD | -23.66% |
2010 | 146.33 Thousand USD | 0.0% |
2009 | - USD | -100.0% |
2008 | 43.86 Thousand USD | -45.17% |
2007 | 80 Thousand USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 771.05 Thousand USD | -0.9% |
2024 Q1 | 778.08 Thousand USD | -0.86% |
2023 Q3 | 784.16 Thousand USD | -1.45% |
2023 FY | 784.82 Thousand USD | 14.13% |
2023 Q2 | 795.73 Thousand USD | 14.12% |
2023 Q1 | 697.28 Thousand USD | 1.4% |
2023 Q4 | 784.82 Thousand USD | 0.08% |
2022 Q4 | 687.64 Thousand USD | -14.77% |
2022 Q2 | 666.01 Thousand USD | 36.18% |
2022 Q1 | 489.08 Thousand USD | 123.32% |
2022 FY | 687.64 Thousand USD | 213.99% |
2022 Q3 | 806.83 Thousand USD | 21.14% |
2021 Q4 | 219 Thousand USD | 5375.0% |
2021 FY | 219 Thousand USD | -60.89% |
2021 Q1 | 25.81 Thousand USD | -95.39% |
2021 Q3 | 4000.00 USD | 0.0% |
2021 Q2 | - USD | -100.0% |
2020 Q1 | 36.93 Thousand USD | -89.9% |
2020 Q3 | 562.99 Thousand USD | 289.79% |
2020 Q4 | 559.95 Thousand USD | -0.54% |
2020 FY | 559.95 Thousand USD | 53.08% |
2020 Q2 | 144.43 Thousand USD | 291.05% |
2019 Q4 | 365.78 Thousand USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 FY | 365.78 Thousand USD | 4404.19% |
2019 Q2 | - USD | -100.0% |
2019 Q1 | 129.12 Thousand USD | 1489.96% |
2018 Q1 | 198.32 Thousand USD | -56.01% |
2018 Q4 | 8121.00 USD | -95.22% |
2018 Q2 | 189.82 Thousand USD | -4.29% |
2018 Q3 | 169.82 Thousand USD | -10.54% |
2018 FY | 8121.00 USD | -98.2% |
2017 Q4 | 450.82 Thousand USD | -2.96% |
2017 Q2 | 447.57 Thousand USD | 9.88% |
2017 FY | 450.82 Thousand USD | 37.31% |
2017 Q1 | 407.32 Thousand USD | 24.06% |
2017 Q3 | 464.57 Thousand USD | 3.8% |
2016 FY | 328.32 Thousand USD | 13.39% |
2016 Q3 | 148.45 Thousand USD | 14.03% |
2016 Q4 | 328.32 Thousand USD | 121.17% |
2016 Q1 | 112.19 Thousand USD | -61.26% |
2016 Q2 | 130.19 Thousand USD | 16.04% |
2015 Q3 | 17.61 Thousand USD | -55.05% |
2015 Q1 | 6000.00 USD | -98.89% |
2015 Q2 | 39.17 Thousand USD | 552.92% |
2015 Q4 | 289.56 Thousand USD | 1544.29% |
2015 FY | 289.56 Thousand USD | -46.65% |
2014 Q2 | 828.97 Thousand USD | 18.73% |
2014 Q4 | 542.77 Thousand USD | -41.23% |
2014 FY | 542.77 Thousand USD | -13.19% |
2014 Q1 | 698.18 Thousand USD | 11.67% |
2014 Q3 | 923.5 Thousand USD | 11.4% |
2013 Q4 | 625.22 Thousand USD | 27.47% |
2013 Q2 | 476.35 Thousand USD | -19.15% |
2013 Q3 | 490.47 Thousand USD | 2.97% |
2013 Q1 | 589.18 Thousand USD | 3.0% |
2013 FY | 625.22 Thousand USD | 9.3% |
2012 Q3 | 120.85 Thousand USD | 2.59% |
2012 FY | 572 Thousand USD | 412.05% |
2012 Q4 | 572 Thousand USD | 373.29% |
2012 Q2 | 117.8 Thousand USD | 2.66% |
2012 Q1 | 114.75 Thousand USD | 2.73% |
2011 FY | 111.7 Thousand USD | -23.66% |
2011 Q1 | 438.73 Thousand USD | 199.82% |
2011 Q3 | 401.52 Thousand USD | 200.09% |
2011 Q2 | 133.8 Thousand USD | -69.5% |
2011 Q4 | 111.7 Thousand USD | -72.18% |
2010 Q2 | 719.31 Thousand USD | 279.55% |
2010 Q3 | 97.19 Thousand USD | -86.49% |
2010 Q4 | 146.33 Thousand USD | 50.56% |
2010 FY | 146.33 Thousand USD | 0.0% |
2010 Q1 | 189.51 Thousand USD | 0.0% |
2009 FY | - USD | -100.0% |
2009 Q1 | 68.86 Thousand USD | 56.99% |
2009 Q2 | 28.86 Thousand USD | -58.08% |
2009 Q3 | 57.3 Thousand USD | 98.52% |
2009 Q4 | - USD | -100.0% |
2008 Q4 | 43.86 Thousand USD | -24.71% |
2008 Q3 | 58.26 Thousand USD | -44.51% |
2008 Q2 | 105 Thousand USD | 0.0% |
2008 Q1 | 105 Thousand USD | 31.25% |
2008 FY | 43.86 Thousand USD | -45.17% |
2007 Q1 | 80 Thousand USD | 0.0% |
2007 FY | 80 Thousand USD | 0.0% |
2007 Q4 | 80 Thousand USD | 0.0% |
2007 Q3 | 80 Thousand USD | 0.0% |
2007 Q2 | 80 Thousand USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Medical Technologies Inc. | 500 Thousand USD | -51.198% |
Ansell Limited | 855.59 Million USD | 99.912% |
Ansell Limited | 857.2 Million USD | 99.912% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 96.627% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 20.93 Thousand USD | -3511.125% |
Psykey, Inc. | 1.01 Million USD | 25.194% |
ConvaTec Group Plc | 1.31 Billion USD | 99.942% |
ConvaTec Group Plc | 1.31 Billion USD | 99.942% |
Encision Inc. | 1.33 Million USD | 43.295% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | 67.255% |
Innovative MedTech Inc. | 1.87 Million USD | 59.75% |
LifePoint, Inc. | 446.74 Thousand USD | -69.223% |
Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 85.985% |
Paradigm Medical Industries, Inc. | 2.18 Million USD | 65.464% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 242.64 Thousand USD | -211.563% |
SmileDirectClub, Inc. | 871.79 Million USD | 99.913% |
Sector 10, Inc. | 164 Thousand USD | -360.969% |
Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.888% |
SheerVision, Inc. | 75 Thousand USD | -907.985% |
Vasamed, Inc. | 23.45 Thousand USD | -3123.834% |
Wearable Health Solutions, Inc. | 2.76 Million USD | 72.682% |
Yubo International Biotech Limited | 790.49 Thousand USD | 4.366% |